Relypsa
VerifiedBiopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$10—16m (Dealroom.co estimates Oct 2012.)
Redwood City California (HQ)
| EUR | 2015 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | $0.0 | round |
| investor investor investor investor investor investor investor | $0.0 | round | |
| investor investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
$1.5b | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Recent News about Relypsa
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.